What is Luminous?
Founded on the principle of enhancing vision and wearer satisfaction, Luminous specializes in the development and distribution of high-definition contact lenses. Their flagship product line, Luminous Pacific, offers weekly and monthly soft contact lenses that feature UV filtration and are designed for superior comfort and visual acuity. The company has successfully obtained U.S. FDA clearance and the European Union CE mark, validating the safety and efficacy of its offerings. This regulatory approval, coupled with a commitment to quality, positions Luminous as a notable player in the global ophthalmic market, aiming to provide contact lens wearers with an improved and reliable vision correction experience.
How much funding has Luminous raised?
Luminous has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Luminous?
With the recent influx of capital from a major strategic investment, Luminous is poised for accelerated expansion and further innovation. The company's late-stage funding context suggests a strategic focus on scaling operations, enhancing its market reach, and potentially broadening its product portfolio within the vision care industry. Future developments may include advancements in lens technology, increased manufacturing capacity, and expanded distribution channels to cater to a growing demand for high-quality, FDA-cleared contact lenses. This strategic financing is expected to solidify Luminous's competitive position and drive its next phase of growth.
See full Luminous company page
